A study protocol for the cardiac effects of a single dose of either oxytocin 2.5 IU or carbetocin 100 µg after caesarean delivery: a prospective randomized controlled multi-centre trial in Norway [version 1; peer review: 2 approved]
Background: Both oxytocin and carbetocin are used to prevent uterine atony and post-partum haemorrhage after caesarean delivery in many countries, including Norway. Oxytocin causes dose-dependent ST-depression, troponin release, prolongation of QT-time and arrythmia, but little is known about myocar...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
F1000 Research Ltd
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/b8a79d929e3149e093132bb3a3af4a80 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|